Ethic Inc. Boosts Stock Position in The Clorox Company (NYSE:CLX)

Ethic Inc. lifted its position in shares of The Clorox Company (NYSE:CLX) by 24.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,583 shares of the company’s stock after purchasing an additional 1,293 shares during the period. Ethic Inc.’s holdings in The Clorox were worth $1,184,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CLX. Champlain Investment Partners LLC purchased a new stake in shares of The Clorox during the first quarter worth about $200,453,000. Nuveen Asset Management LLC lifted its holdings in The Clorox by 24.4% in the first quarter. Nuveen Asset Management LLC now owns 1,017,623 shares of the company’s stock worth $196,280,000 after buying an additional 199,542 shares during the period. Armistice Capital LLC lifted its holdings in The Clorox by 316.7% in the first quarter. Armistice Capital LLC now owns 250,000 shares of the company’s stock worth $48,220,000 after buying an additional 190,000 shares during the period. Canada Pension Plan Investment Board lifted its holdings in The Clorox by 677.8% in the first quarter. Canada Pension Plan Investment Board now owns 174,767 shares of the company’s stock worth $33,709,000 after buying an additional 152,297 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in shares of The Clorox by 65.4% during the first quarter. JPMorgan Chase & Co. now owns 300,152 shares of the company’s stock valued at $57,894,000 after purchasing an additional 118,651 shares in the last quarter. Institutional investors own 77.77% of the company’s stock.

Several equities research analysts recently weighed in on CLX shares. Deutsche Bank Aktiengesellschaft reduced their price target on shares of The Clorox from $192.00 to $153.00 and set a “hold” rating for the company in a research report on Wednesday, August 4th. Argus downgraded shares of The Clorox from a “buy” rating to a “hold” rating in a research report on Friday, September 3rd. Credit Suisse Group reduced their price target on shares of The Clorox from $175.00 to $160.00 and set a “neutral” rating for the company in a research report on Wednesday, August 4th. Morgan Stanley cut their target price on shares of The Clorox from $170.00 to $160.00 and set an “underweight” rating for the company in a research report on Wednesday, August 4th. Finally, Zacks Investment Research downgraded shares of The Clorox from a “hold” rating to a “strong sell” rating and set a $139.00 target price for the company. in a research report on Friday, August 6th. Five research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $182.44.

The Clorox stock opened at $172.24 on Wednesday. The company’s 50-day moving average price is $173.34 and its 200-day moving average price is $180.04. The Clorox Company has a twelve month low of $159.32 and a twelve month high of $231.11. The company has a quick ratio of 0.52, a current ratio of 0.89 and a debt-to-equity ratio of 4.20. The company has a market cap of $21.15 billion, a PE ratio of 31.09, a price-to-earnings-growth ratio of 4.37 and a beta of 0.21.

The Clorox (NYSE:CLX) last issued its quarterly earnings results on Tuesday, August 3rd. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.29 by ($0.34). The firm had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.91 billion. The Clorox had a net margin of 9.67% and a return on equity of 94.42%. The business’s revenue for the quarter was down 9.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.41 earnings per share. As a group, sell-side analysts expect that The Clorox Company will post 5.54 earnings per share for the current fiscal year.

About The Clorox

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.

Featured Story: Trade War

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.